PATENT CLAIM ANALYSIS

Application Number: 16134162
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "232200"]

Abstract:
The present invention is related to tablets comprising of 2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide, processes for the production thereof, and uses in the treatment of certain cancers.

Claim (Index 20):
A method of treating cancer in an individual in need thereof, comprising administering to the individual the tablet of  claim 1 .

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.20588
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15328661', '15969519', '13019718', '13793864', '13915702']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8143291389890213
- 35 USC 102 Novelty (BERT): 0.585559392792823
- Combined Prediction Score: 0.7914521643694015
- Mean Citation Score: 462.060758
- Max Citation Score: 592.0069
- Similarity Product: 395.2242509916902

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test